Published in

American Association for Cancer Research, Cancer Immunology Research, 2(5), p. 170-179

DOI: 10.1158/2326-6066.cir-16-0288

Links

Tools

Export citation

Search in Google Scholar

Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO